Long Term Outcome of Congenital Solitary Kidney (CSKP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01831141|
Recruitment Status : Unknown
Verified April 2013 by Giovanni Montini, Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi.
Recruitment status was: Recruiting
First Posted : April 15, 2013
Last Update Posted : April 15, 2013
Congenital solitary kidney (CSK) is a disorder caused by an abnormal development of one of the two kidneys. The reported incidence ranges between 1:450-3200. It is debated whether CSK is a benign condition or not. A variable risk of developing proteinuria (11-27%), hypertension (0-60%) and chronic kidney damage (3.5-30%) is described. This knowledge derives mainly from retrospective studies performed in tertiary medical centers which is difficult to compare for the following reasons: the number of individuals evaluated, the length of follow-up and the outcome studied.
The aim of this longitudinal study is to assess, in a cohort of children with congenital solitary kidney, during a 10 year follow-up period: 1) the rates of developing proteinuria, hypertension and chronic kidney disease and the corresponding potential prognostic factors. 2) the role of new biomarkers of glomerular (Cystatin C) or tubular damage (NGAL, NAG, B2-microglobulin) in predicting the appearance of chronic kidney damage.
|Condition or disease|
|Congenital Solitary Kidney|
|Study Type :||Observational|
|Estimated Enrollment :||120 participants|
|Official Title:||Renal Outcome in Children With Congenital Solitary Kidney: a Longitudinal Prognostic Study|
|Study Start Date :||June 2010|
|Estimated Primary Completion Date :||June 2013|
|Estimated Study Completion Date :||June 2013|
- Chronic kidney disease [ Time Frame: 10 years ]Chronic kidney disease defined by National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents with a glomerular filtration rate less than 89 ml/min/1.73 m2.
- Proteinuria [ Time Frame: 10 years ]Proteinuria defined by the National Kidney Foundation's Kidney Disease Outcomes Quality Initiative as a urine protein/urine creatinine ratio of more than 0.5 in children younger six months and of more than 0.2 in older children.
- Hypertension [ Time Frame: 10 years ]Hypertension defined by the National High Blood Pressure Education Program Working Group as a blood pressure ≥ 95th percentile
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01831141
|Contact: Giovanni Montini, MDemail@example.com|
|Contact: Claudio La Scola, MDfirstname.lastname@example.org|
|Azienda Ospedaliero-Universitaria Sant'Orsola Malpighi,||Recruiting|
|Bologna, Emilia Romagna, Italy, 40100|
|Study Chair:||Giovanni Montini, MD||Azienda Ospedaliero-Universitaria Sant'Orsola Malpighi, Bologna, Italy|